• Explore /
  • Poster
  • / Pathological response to neoadjuvant gemcitabine plus nabpaclitaxel in pancreatic adenocarcinoma to improve survival.

Pathological response to neoadjuvant gemcitabine plus nabpaclitaxel in pancreatic adenocarcinoma to improve survival.

Abstract Poster

Authors

null

Rafael Alvarez-Gallego

Centro Integral Oncológico Clara Campal- Hospital Madrid Norte Sanchinarro, Madrid, Spain

Rafael Alvarez-Gallego , Antonio Cubillo , Elena Garralda , Estela Vega , Jesus Rodriguez-Pascual , Lisardo Ugidos , Emilio De Vicente , Yolanda Quijano , Carmen Rubio , Ovidio Hernando , Carlos Plaza , Fernando Lopez-Rios , Manuel Hidalgo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Citation

J Clin Oncol 34, 2016 (suppl; abstr 4109)

DOI

10.1200/JCO.2016.34.15_suppl.4109

Abstract #

4109

Poster Bd #

101

Abstract Disclosures

Similar Posters

First Author: Vincent J. Picozzi

First Author: Vincent J. Picozzi

First Author: Vincent J. Picozzi

First Author: Colin Hill